Russia’s healthtech sector is undergoing rapid transformation, driven by advances in digital technologies and increasing demand for accessible and efficient healthcare. As new opportunities emerge, so do challenges — particularly in navigating legal and regulatory frameworks. This article offers an in-depth analysis of telemedicine, data protection, liability and regulatory challenges — key legal aspects influencing healthtech in Russia.
Telemedicine
Managing Director
KP Moscow
Email: oskin@kpmoscow.ru
Telemedicine, or the use of digital technologies to deliver remote medical services, has been a cornerstone of global healthtech development. In Russia, this domain is governed by the Federal Law on the Fundamentals of Public Health Protection and various decrees by the Ministry of Health. Telemedicine is defined as an interaction between healthcare professionals and patients using information and communication technologies for medical consultations and observations.
Russian legislation permits healthcare providers to offer telemedicine services only if they hold a state medical licence, ensuring compliance with medical standards. Telemedicine platforms must also meet security and technical standards approved by regulators. Notably, initial consultations must occur in person, limiting the full potential of telemedicine in reducing physical healthcare barriers. Current regulations also prioritise doctor-to-doctor consultations over direct doctor-patient interactions, presenting a significant gap for the sector’s growth.
Despite these limitations, telemedicine has witnessed growth, particularly during the covid-19 pandemic. Regulatory amendments allowed remote issuance of prescriptions and consultations for non-emergency cases, highlighting potential for further modernisation of telemedicine laws in Russia. Many stakeholders emphasise a need for comprehensive legislative reform to enable broader adoption of telemedicine solutions, particularly in rural areas.
Another challenge is integrating telemedicine into Russia’s existing healthcare infrastructure. This requires not only regulatory changes but also significant investments in digital tools, training for healthcare professionals, and public awareness campaigns that build trust in remote healthcare services.
A potential step forward could involve pilot programmes that allow initial telemedicine consultations for specific conditions, paving the way for broader legislative changes. Further incentives such as tax benefits or grants could encourage private investment in telemedicine infrastructure, accelerating its growth and adoption.
Data protection
The protection of personal data, particularly sensitive health-related information, is one of the most critical legal considerations for healthtech. Russia’s Federal Law on Personal Data governs the collection, processing and storage of personal data, including health data. While the law does not explicitly define health data as a separate category, its sensitivity places it under stricter regulatory oversight.
Some of the key obligations for healthtech companies are set out below.
Consent. Companies must obtain explicit and informed consent from individuals before processing their health data. Consent forms must be clear, easily accessible and comply with local standards.
Localisation rules. Russian law mandates that all Russian citizens’ prsonal data is stored on servers within the country. This presents challenges for healthtech companies utilising cloud services or international data-sharing platforms.
Security. Organisations must implement robust technical and organisational measures to protect data from breaches. This includes encryption, access control and regular security audits.
Crossing borders
Cross-border data transfers are strictly regulated; companies must ensure recipient countries provide adequate data protection. In practice, this means obtaining regulatory approval for data transfers to jurisdictions not recognised as providing adequate protection, such as the US.
Challenges specific to data localisation include the added costs of establishing local data centres and ensuring compliance with divergent legal frameworks when operating in multiple jurisdictions. However, some companies have turned this into an opportunity by partnering with local service providers to enhance data security while fostering trust from regulators and consumers. Additionally, developing localised solutions for secure data processing can position companies as industry leaders within Russia.
Common challenges
Penalties. Breaches of data protection laws can result in significant fines, operational restrictions and reputational damage. Recent actions by Roskomnadzor demonstrate an increasing focus on enforcing compliance from the healthtech sector.
Data breaches. Given the sensitive nature of health data, breaches can lead to significant legal and financial repercussions. Healthtech companies must invest in cybersecurity infrastructure to mitigate risk.
The importance of data protection in healthtech cannot be overstated. As digital solutions continue to transform healthcare, companies must navigate complex regulatory landscapes to build trust with users and ensure compliance. Developing best practices for data protection and engaging in ongoing dialogue with regulators will be crucial to fostering innovation in the sector.
Liability
Healthtech introduces unique liability challenges. While traditional healthcare providers are accustomed to medical malpractice laws, the integration of digital solutions creates new questions of accountability.
Healthcare providers. Healthcare professionals remain responsible for the medical services they provide, even when using digital tools. For instance, if a diagnostic error occurs due to faulty software, the professional may still bear legal responsibility unless it can be demonstrated that the software provider’s negligence was the primary cause.
Software developers. Developers of digital health tools must ensure their products meet standards for safety and reliability. Any defects in software that lead to harm may expose developers to liability claims. For example, an application that provides incorrect medication dosages could result in both legal and reputational consequences for the developer.
Product laws. In addition to healthcare-specific regulations, general product liability laws apply to healthtech products. Companies must conduct thorough testing and quality assurance to minimise risk and demonstrate compliance with legal standards. This includes obtaining certifications for medical devices and ensuring interoperability with other healthcare systems to avoid complications.
Future directions
Despite progress, significant challenges remain in the regulatory landscape for Russia’s healthtech sector. Key areas for improvement include:
Integration of AI. The use of artificial intelligence (AI) in diagnostics and treatment planning requires a regulatory framework that balances innovation with safety. This includes ensuring transparency in AI algorithms and addressing concerns about potential biases in decision-making processes.
Patient access. Patients currently face barriers to accessing their health records. Simplifying these processes through digitalisation and centralisation could enhance patient autonomy and engagement. However, this raises additional concerns about data security and the need for robust systems to prevent unauthorised access.
Initial diagnoses. Regulations limiting initial diagnoses to in-person consultations hinder the growth of telemedicine. Modernising these rules could unlock the full potential of digital health, especially in remote areas. Pilot programmes could help demonstrate the safety and efficacy of remote initial consultations for specific conditions.
Fostering PPP. Collaboration between the government and the private sector can accelerate innovation in healthtech. Public-private partnerships could focus on developing shared infrastructure, funding research and streamlining regulatory processes. These partnerships may also facilitate knowledge sharing and foster a more cohesive approach to tackling common challenges in the sector.
Education. Investing in educational programmes for healthcare professionals and developers is essential to bridge knowledge gaps and equip stakeholders with skills to navigate the evolving landscape of digital health. Establishing partnerships with academic institutions to create specialised healthtech courses could be a game-changer for fostering a well-trained workforce.
International collaboration. While Russia’s regulatory frameworks emphasise data localisation and strict compliance, collaboration with international organisations could bring valuable insights and innovation. Establishing joint research projects or technology exchanges could bridge gaps and support the development of cutting-edge solutions.
Conclusion
The healthtech sector in Russia is at a crossroads. While the legal framework provides a foundation for innovation, significant gaps and challenges must be addressed to foster sustainable growth. Enhanced data protection measures, streamlined telemedicine regulations and clarified liability provisions will be pivotal in unlocking the sector’s potential.
With the right regulatory changes and strategic investments, Russia has an opportunity to become a global leader in digital healthcare. Collaboration between regulators, healthcare providers and technology developers will be essential to building a future-ready healthcare ecosystem that benefits all stakeholders. The inclusion of international best practices and a focus on public trust will further strengthen the sector’s resilience and capacity for innovation.
KP MOSCOWKorobeynikov per. 22 str. 3, 119034 Moscow
Tel: +7 495 6443123
Email: oskin@kpmoscow.ru;
smirnova@kpmoscow.ru
www.kpmoscow.ru/en/
